How can erythropoeitin-stimulating agent use be reduced in chronic dialysis patients?: Can reduction of inflammation improve ESA dose response?
作者信息
Kovesdy Csaba P
机构信息
Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center and Memphis VA Medical Center, Memphis, Tennessee.
出版信息
Semin Dial. 2013 Sep-Oct;26(5):540-2. doi: 10.1111/sdi.12107. Epub 2013 Jun 5.
PMID:23734775
Abstract
摘要
Zotero 插件